Back to Journals » OncoTargets and Therapy » Volume 12

miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib

Total article views   HTML views PDF downloads Totals
4,768 Dovepress* 4,316+ 825 5,141
PubMed Central* 452 147 599
Totals 4,768 972 5,740
*Since 21 August 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 1 0 0 0 1

View citations on PubMed Central and Google Scholar